{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T01:24:26Z","timestamp":1789176266717,"version":"build-2803163510"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T00:00:00Z","timestamp":1672704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T00:00:00Z","timestamp":1672704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2019YFE0111700"],"award-info":[{"award-number":["2019YFE0111700"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.81971517"],"award-info":[{"award-number":["No.81971517"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s10067-022-06464-w","type":"journal-article","created":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T04:22:14Z","timestamp":1672719734000},"page":"1451-1457","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Eltrombopag in severe immune thrombocytopenia secondary to connective tissue disease: a report of 17 patients and literature review"],"prefix":"10.1007","volume":"42","author":[{"given":"Wenjing","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingzhu","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9837-9690","authenticated-orcid":false,"given":"Xuebing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,3]]},"reference":[{"key":"6464_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2014-000078","volume":"2","author":"A Fayyaz","year":"2015","unstructured":"Fayyaz A, Igoe A, Kurien BT, Danda D, James JA, Stafford HA et al (2015) Haematological manifestations of lupus. Lupus Sci Med 2:e000078. https:\/\/doi.org\/10.1136\/lupus-2014-000078","journal-title":"Lupus Sci Med"},{"key":"6464_CR2","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1111\/1756-185X.13464","volume":"22","author":"M Tsukamoto","year":"2019","unstructured":"Tsukamoto M, Suzuki K, Takeuchi T (2019) Ten-year observation of patients with primary Sjogren\u2019s syndrome: initial presenting characteristics and the associated outcomes. Int J Rheum Dis 22:929\u2013933. https:\/\/doi.org\/10.1111\/1756-185X.13464","journal-title":"Int J Rheum Dis"},{"key":"6464_CR3","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000011356","volume":"97","author":"J Li","year":"2018","unstructured":"Li J, Pan Z, Liu H, Ding F, Shu Q, Li X (2018) Retrospective analysis of the risk of hemorrhage associated with moderate and severe thrombocytopenia of 173 patients with systemic lupus erythematosus. Medicine (Baltimore) 97:e11356. https:\/\/doi.org\/10.1097\/MD.0000000000011356","journal-title":"Medicine (Baltimore)"},{"key":"6464_CR4","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.1007\/s10067-018-4312-y","volume":"37","author":"W Zhang","year":"2018","unstructured":"Zhang W, Wang F, Wang H, Hua B, Feng X, Sun L (2018) Severe thrombocytopenia in connective tissue diseases: a single-center review of 131 cases. Clin Rheumatol 37:3337\u20133344. https:\/\/doi.org\/10.1007\/s10067-018-4312-y","journal-title":"Clin Rheumatol"},{"key":"6464_CR5","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S0140-6736(09)60402-5","volume":"373","author":"JB Bussel","year":"2009","unstructured":"Bussel JB, Provan D, Shamsi T, Cheng G, Psaila B, Kovaleva L et al (2009) Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial. Lancet 373:641\u2013648. https:\/\/doi.org\/10.1016\/S0140-6736(09)60402-5","journal-title":"Lancet"},{"key":"6464_CR6","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1634\/stemcells.2008-0366","volume":"27","author":"CL Erickson-Miller","year":"2009","unstructured":"Erickson-Miller CL, Delorme E, Tian SS, Hopson CB, Landis AJ, Valoret EI et al (2009) Preclinical activity of eltrombopag (SB-497115), an oral, nonpeptide thrombopoietin receptor agonist. Stem Cells 27:424\u2013430. https:\/\/doi.org\/10.1634\/stemcells.2008-0366","journal-title":"Stem Cells"},{"key":"6464_CR7","doi-asserted-by":"publisher","first-page":"567","DOI":"10.2165\/00003495-200969050-00005","volume":"69","author":"KP Garnock-Jones","year":"2009","unstructured":"Garnock-Jones KP, Keam SJ (2009) Eltrombopag. Drugs 69:567\u2013576. https:\/\/doi.org\/10.2165\/00003495-200969050-00005","journal-title":"Drugs"},{"key":"6464_CR8","first-page":"806","volume":"8","author":"I Cela","year":"2010","unstructured":"Cela I, Miller IJ, Katz RS, Rizman A, Shammo JM (2010) Successful treatment of amegakaryocytic thrombocytopenia with eltrombopag in a patient with systemic lupus erythematosus (SLE). Clin Adv Hematol Oncol 8:806\u2013809","journal-title":"Clin Adv Hematol Oncol"},{"key":"6464_CR9","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/jcpt.13321","volume":"46","author":"Q Leng","year":"2021","unstructured":"Leng Q, Wang W, Wang Y, Wu L (2021) Treatment of severe thrombocytopenia associated with systemic lupus erythematosus in pregnancy with eltrombopag: a case report and literature review. J Clin Pharm Ther 46:532\u2013538. https:\/\/doi.org\/10.1111\/jcpt.13321","journal-title":"J Clin Pharm Ther"},{"key":"6464_CR10","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1177\/0961203314559632","volume":"24","author":"MC Maroun","year":"2015","unstructured":"Maroun MC, Ososki R, Andersen JC, Dhar JP (2015) Eltrombopag as steroid sparing therapy for immune thrombocytopenic purpura in systemic lupus erythematosus. Lupus 24:746\u2013750. https:\/\/doi.org\/10.1177\/0961203314559632","journal-title":"Lupus"},{"key":"6464_CR11","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1007\/s10067-014-2600-8","volume":"33","author":"P Scheinberg","year":"2014","unstructured":"Scheinberg P, Singulane CC, Barbosa LS, Scheinberg M (2014) Successful platelet count recovery in lupus-associated thrombocytopenia with the thrombopoietin agonist eltrombopag. Clin Rheumatol 33:1347\u20131349. https:\/\/doi.org\/10.1007\/s10067-014-2600-8","journal-title":"Clin Rheumatol"},{"key":"6464_CR12","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1097\/RHU.0000000000001083","volume":"26","author":"V Shobha","year":"2020","unstructured":"Shobha V, Sanil S, Roongta R (2020) Eltrombopag: efficacy and safety in steroid refractory lupus-associated immune thrombocytopenia. J Clin Rheumatol 26:274\u2013278. https:\/\/doi.org\/10.1097\/RHU.0000000000001083","journal-title":"J Clin Rheumatol"},{"key":"6464_CR13","doi-asserted-by":"publisher","first-page":"5459","DOI":"10.1038\/s41598-021-84493-2","volume":"11","author":"J Wang","year":"2021","unstructured":"Wang J, Dai M, Fu Q, Chen S (2021) Eltrombopag for the treatment of refractory thrombocytopenia associated with connective tissue disease. Sci Rep 11:5459. https:\/\/doi.org\/10.1038\/s41598-021-84493-2","journal-title":"Sci Rep"},{"key":"6464_CR14","doi-asserted-by":"publisher","first-page":"6305356","DOI":"10.1155\/2018\/6305356","volume":"2018","author":"N Shima","year":"2018","unstructured":"Shima N, Sumida K, Kawada M, Sekine A, Yamanouchi M, Hiramatsu R et al (2018) Eltrombopag improves refractory thrombocytopenia in a patient with systemic lupus erythematosus. Case Rep Rheumatol 2018:6305356. https:\/\/doi.org\/10.1155\/2018\/6305356","journal-title":"Case Rep Rheumatol"},{"key":"6464_CR15","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1002\/art.34473","volume":"64","author":"M Petri","year":"2012","unstructured":"Petri M, Orbai AM, Alarcon GS, Gordon C, Merrill JT, Fortin PR et al (2012) Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64:2677\u20132686. https:\/\/doi.org\/10.1002\/art.34473","journal-title":"Arthritis Rheum"},{"key":"6464_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/art.39859","volume":"69","author":"CH Shiboski","year":"2017","unstructured":"Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM et al (2017) 2016 American College of Rheumatology\/European League against rheumatism classification criteria for primary Sjogren\u2019s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol 69:35\u201345. https:\/\/doi.org\/10.1002\/art.39859","journal-title":"Arthritis Rheumatol"},{"key":"6464_CR17","first-page":"S14","volume":"22","author":"M Mosca","year":"2004","unstructured":"Mosca M, Baldini C, Bombardieri S (2004) Undifferentiated connective tissue diseases in 2004. Clin Exp Rheumatol 22:S14\u2013S18","journal-title":"Clin Exp Rheumatol"},{"key":"6464_CR18","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.3324\/haematol.2018.212845","volume":"104","author":"W Ghanima","year":"2019","unstructured":"Ghanima W, Cooper N, Rodeghiero F, Godeau B, Bussel JB (2019) Thrombopoietin receptor agonists: ten years later. Haematologica 104:1112\u20131123. https:\/\/doi.org\/10.3324\/haematol.2018.212845","journal-title":"Haematologica"},{"key":"6464_CR19","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.autrev.2017.04.012","volume":"16","author":"S Audia","year":"2017","unstructured":"Audia S, Mahevas M, Samson M, Godeau B, Bonnotte B (2017) Pathogenesis of immune thrombocytopenia. Autoimmun Rev 16:620\u2013632. https:\/\/doi.org\/10.1016\/j.autrev.2017.04.012","journal-title":"Autoimmun Rev"},{"key":"6464_CR20","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3760\/cma.j.issn.0578-1426.2019.04.009","volume":"58","author":"Y Xue","year":"2019","unstructured":"Xue Y, Xu D, Li MT, Zeng XF (2019) [Marrow megakaryocyte count as a response predictor of severe thrombocytopenia in patients with primary Sjogren syndrome]. Zhonghua Nei Ke Za Zhi 58:282\u20137. https:\/\/doi.org\/10.3760\/cma.j.issn.0578-1426.2019.04.009","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"6464_CR21","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.3899\/jrheum.150829","volume":"43","author":"L Zhao","year":"2016","unstructured":"Zhao L, Xu D, Qiao L, Zhang X (2016) Bone marrow megakaryocytes may predict therapeutic response of severe thrombocytopenia in patients with systemic lupus erythematosus. J Rheumatol 43:1038\u20131044. https:\/\/doi.org\/10.3899\/jrheum.150829","journal-title":"J Rheumatol"},{"key":"6464_CR22","doi-asserted-by":"publisher","first-page":"904","DOI":"10.3892\/etm.2021.10336","volume":"22","author":"A Bojan","year":"2021","unstructured":"Bojan A, Parvu A, Zsoldos IA, Torok T, Farcas AD (2021) Macrophage activation syndrome: a diagnostic challenge (Review). Exp Ther Med 22:904. https:\/\/doi.org\/10.3892\/etm.2021.10336","journal-title":"Exp Ther Med"},{"key":"6464_CR23","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.jacl.2013.09.003","volume":"7","author":"DE Okorodudu","year":"2013","unstructured":"Okorodudu DE, Crowley MJ, Sebastian S, Rowell JV, Guyton JR (2013) Inherited lipemic splenomegaly and the spectrum of apolipoprotein E p.Leu167del mutation phenotypic variation. J Clin Lipidol 7:566\u201372. https:\/\/doi.org\/10.1016\/j.jacl.2013.09.003","journal-title":"J Clin Lipidol"},{"key":"6464_CR24","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1093\/rheumatology\/key119","volume":"57","author":"Z Guitton","year":"2018","unstructured":"Guitton Z, Terriou L, Lega JC, Nove-Josserand R, Hie M, Amoura Z et al (2018) Risk of thrombosis with anti-phospholipid syndrome in systemic lupus erythematosus treated with thrombopoietin-receptor agonists. Rheumatology (Oxford) 57:1432\u20131438. https:\/\/doi.org\/10.1093\/rheumatology\/key119","journal-title":"Rheumatology (Oxford)"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06464-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-022-06464-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06464-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T10:16:30Z","timestamp":1681380990000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-022-06464-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,3]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["6464"],"URL":"https:\/\/doi.org\/10.1007\/s10067-022-06464-w","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,3]]},"assertion":[{"value":"27 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}